DSP Healthcare Fund Regular Growth

Fund Overview

Fund Size

₹3,835 Cr

Expense Ratio

2.04%

ISIN

INF740KA1LD8

Minimum SIP

₹100

Exit Load

No Charges

Inception Date

30 Nov 2018

About this fund

DSP Healthcare Fund Regular Growth is a Sector - Healthcare mutual fund schemes offered by DSP Mutual Fund. This fund has been in existence for 7 years, 9 months and 28 days, having been launched on 30-Nov-18.
As of 25-Sep-26, it has a Net Asset Value (NAV) of ₹45.74, Assets Under Management (AUM) of 3835.28 Crores, and an expense ratio of 2.04%.

DSP Healthcare Fund Regular Growth has given a CAGR return of 21.46% since inception.
The fund's asset allocation comprises around 97.13% in equities, 0.00% in debts, and 2.87% in cash & cash equivalents.
You can start investing in DSP Healthcare Fund Regular Growth with a SIP of ₹100 or a Lumpsum investment of ₹100.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+17.37%

+18.68% (Cat Avg.)

3 Years

+21.34%

+21.74% (Cat Avg.)

5 Years

+14.34%

+14.39% (Cat Avg.)

Since Inception

+21.46%

— (Cat Avg.)

Portfolio Summaryas of 31st August 2026

Equity	₹3,725.06 Cr	97.13%
Others	₹110.22 Cr	2.87%

Top Holdings

All Holdings

Equity

Debt & Others

Name	Type	Amount	Holdings
Ipca Laboratories Ltd	Equity	₹335.02 Cr	8.74%
Sun Pharmaceuticals Industries Ltd	Equity	₹304.78 Cr	7.95%
Sai Life Sciences Ltd	Equity	₹285.72 Cr	7.45%
Cipla Ltd	Equity	₹282.03 Cr	7.35%
Apollo Hospitals Enterprise Ltd	Equity	₹248.03 Cr	6.47%
Gland Pharma Ltd	Equity	₹229.5 Cr	5.98%
Globus Medical Inc Class A	Equity	₹208.77 Cr	5.44%
Divi's Laboratories Ltd	Equity	₹159.26 Cr	4.15%
Alkem Laboratories Ltd	Equity	₹156.61 Cr	4.08%
Cohance Lifesciences Ltd	Equity	₹146.04 Cr	3.81%
Treps / Reverse Repo Investments	Cash - Repurchase Agreement	₹144.58 Cr	3.77%
Manipal Health Enterprises Ltd	Equity	₹141.84 Cr	3.70%
Pfizer Ltd	Equity	₹123.49 Cr	3.22%
Alembic Pharmaceuticals Ltd	Equity	₹120.44 Cr	3.14%
Kovai Medical Center & Hospital Ltd	Equity	₹107.41 Cr	2.80%
Concord Biotech Ltd	Equity	₹106.41 Cr	2.77%
Vijaya Diagnostic Centre Ltd	Equity	₹93.49 Cr	2.44%
Procter & Gamble Health Ltd	Equity	₹91.88 Cr	2.40%
Thyrocare Technologies Ltd	Equity	₹81.07 Cr	2.11%
Indoco Remedies Ltd	Equity	₹78.98 Cr	2.06%
Intuitive Surgical Inc	Equity	₹67.51 Cr	1.76%
Unichem Laboratories Ltd	Equity	₹62.82 Cr	1.64%
Syngene International Ltd	Equity	₹50.08 Cr	1.31%
Nephrocare Health Services Ltd	Equity	₹43.37 Cr	1.13%
ICICI Lombard General Insurance Co Ltd	Equity	₹37.83 Cr	0.99%
Global X Genomics & Biotechnology ETF	Mutual Fund - ETF	₹37.66 Cr	0.98%
Aarti Drugs Ltd	Equity	₹35.08 Cr	0.91%
Net Receivables/Payables	Cash	₹-34.37 Cr	0.90%
Abbott Laboratories	Equity	₹33.29 Cr	0.87%
Eris Lifesciences Ltd Registered Shs	Equity	₹29.3 Cr	0.76%
Jupiter Life Line Hospitals Ltd	Equity	₹15.27 Cr	0.40%
GRAIL Inc	Equity	₹6.62 Cr	0.17%
Laxmi Dental Ltd	Equity	₹5.48 Cr	0.14%

Allocation By Market Cap (Equity)

Other Allocation

Equity Sector

Debt & Others

Sector	Amount	Holdings
Healthcare	₹3,649.57 Cr	95.16%
Financial Services	₹37.83 Cr	0.99%

Risk & Performance Ratios

Fund Managers

Chirag Dagli

Since December 2020

Additional Scheme Detailsas of 31st August 2026

ISIN

INF740KA1LD8

Expense Ratio

2.04%

Exit Load

No Charges

Fund Size

₹3,835 Cr

Age

7 years 9 months

Lumpsum Minimum

₹100

Fund Status

Open Ended Investment Company

Benchmark

BSE Healthcare TR INR

Investment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Capital Gains Taxation:

Dividend Taxation:

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Invesco India Pharma and Healthcare Fund Regular Growth Very High Risk	-	0.0%	-	-
Invesco India Pharma and Healthcare Fund Direct Growth Very High Risk	-	0.0%	-	-
DSP Nifty Healthcare ETF Very High Risk	0.3%	-	₹18.12 Cr	15.7%
Groww BSE Hospitals ETF Very High Risk	0.6%	-	₹158.55 Cr	-
Mirae Asset Nifty 500 Healthcare ETF Very High Risk	0.3%	-	₹15.08 Cr	-
Bandhan Healthcare Fund Direct Growth Very High Risk	1.2%	0.0%	₹331.57 Cr	-
Bandhan Healthcare Fund Regular Growth Very High Risk	2.8%	0.0%	₹331.57 Cr	-
Baroda BNP Paribas Health and Wellness Fund Direct Growth Very High Risk	1.0%	1.0%	₹507.42 Cr	13.6%
Baroda BNP Paribas Health and Wellness Fund Regular Growth Very High Risk	2.5%	1.0%	₹507.42 Cr	11.7%
Bajaj Finserv Healthcare Fund Regular Growth Very High Risk	2.6%	1.0%	₹405.91 Cr	21.9%
Bajaj Finserv Healthcare Fund Direct Growth Very High Risk	0.9%	1.0%	₹405.91 Cr	24.0%
PGIM India Healthcare Fund Direct Growth Very High Risk	0.9%	0.0%	₹125.15 Cr	26.8%
PGIM India Healthcare Fund Regular Growth Very High Risk	2.6%	0.0%	₹125.15 Cr	24.7%
WhiteOak Capital Pharma and Healthcare Fund Regular Growth Very High Risk	2.8%	0.0%	₹902.24 Cr	23.3%
WhiteOak Capital Pharma and Healthcare Fund Direct Growth Very High Risk	1.1%	0.0%	₹902.24 Cr	25.4%
DSP Nifty Healthcare ETF Regular Growth Very High Risk	0.2%	-	₹14.94 Cr	11.4%
Kotak Healthcare Fund Direct Growth Very High Risk	1.1%	0.0%	₹767.70 Cr	30.7%
Kotak Healthcare Fund Regular Growth Very High Risk	2.6%	0.0%	₹767.70 Cr	28.6%
HDFC Pharma and Healthcare Fund Regular Growth Very High Risk	2.2%	1.0%	₹3310.64 Cr	27.4%
HDFC Pharma and Healthcare Fund Direct Growth Very High Risk	1.1%	1.0%	₹3310.64 Cr	28.8%
Nippon India Pharma Fund Direct Growth Very High Risk	1.0%	1.0%	₹9479.08 Cr	13.7%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Regular Growth Very High Risk	2.1%	1.0%	₹6995.62 Cr	8.5%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth Very High Risk	1.3%	1.0%	₹6995.62 Cr	9.3%
DSP Healthcare Fund Direct Growth Very High Risk	0.7%	0.0%	₹3835.28 Cr	18.9%
DSP Healthcare Fund Regular Growth Very High Risk	2.0%	0.0%	₹3835.28 Cr	17.4%
LIC MF Healthcare Fund Direct Growth Very High Risk	1.4%	1.0%	₹103.11 Cr	18.7%
LIC MF Healthcare Fund Regular Growth Very High Risk	2.7%	1.0%	₹103.11 Cr	17.1%
quant Healthcare Fund Direct Growth Very High Risk	1.5%	1.0%	₹428.30 Cr	21.1%
quant Healthcare Fund Regular Growth Very High Risk	3.1%	1.0%	₹428.30 Cr	19.1%
UTI Healthcare Fund Direct Growth Very High Risk	1.3%	1.0%	₹1443.57 Cr	19.0%
SBI Healthcare Opportunities Fund Direct Growth Very High Risk	1.0%	0.0%	₹5796.42 Cr	23.1%
Tata India Pharma & Healthcare Fund Regular Growth Very High Risk	2.3%	0.0%	₹1565.28 Cr	8.8%
Tata India Pharma & Healthcare Fund Direct Growth Very High Risk	1.0%	0.0%	₹1565.28 Cr	10.4%
ICICI Prudential Nifty Healthcare ETF Very High Risk	0.2%	-	₹236.93 Cr	15.8%
SBI Healthcare Opportunities Fund Regular Growth Very High Risk	2.0%	0.0%	₹5796.42 Cr	21.9%
Nippon India Pharma Fund Regular Growth Very High Risk	1.8%	1.0%	₹9479.08 Cr	12.7%
UTI Healthcare Fund Regular Growth Very High Risk	2.2%	1.0%	₹1443.57 Cr	17.9%
Axis NIFTY Healthcare ETF Very High Risk	0.4%	-	₹24.23 Cr	15.6%
Nippon India Nifty Pharma ETF Very High Risk	0.2%	-	₹1760.51 Cr	23.3%
Mirae Asset Healthcare Fund Regular Growth Very High Risk	1.6%	1.0%	₹3555.18 Cr	20.4%
Mirae Asset Healthcare Fund Direct Growth Very High Risk	0.5%	1.0%	₹3555.18 Cr	22.1%
ITI Pharma and Healthcare Fund Regular Growth Very High Risk	2.6%	0.0%	₹276.23 Cr	13.2%
ITI Pharma and Healthcare Fund Direct Growth Very High Risk	0.9%	0.0%	₹276.23 Cr	15.2%
Aditya Birla Sun Life Nifty Healthcare ETF Very High Risk	0.2%	-	₹83.40 Cr	15.8%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth Very High Risk	2.3%	1.0%	₹1102.73 Cr	18.4%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Very High Risk	1.0%	1.0%	₹1102.73 Cr	20.0%
Motilal Oswal S&P BSE Healthcare ETF Very High Risk	0.4%	-	₹44.84 Cr	17.7%

About the AMC

DSP Mutual Fund

+91 18002084499

https://www.dspim.com/

Total AUM

₹2,42,987 Cr

Address

West Wing, 11th Floor, Mumbai, 400021

Other Funds by DSP Mutual Fund

Fund name	Expense Ratio	Exit Load	Fund size	1Y
DSP Financial Services Sectoral Debt Fund Direct Growth Moderate Risk	0.2%	0.0%	-	-
DSP Multi Asset Omni Fund of Funds Direct Growth Very High Risk	0.9%	0.0%	₹882.89 Cr	-
DSP Nifty 500 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹16.23 Cr	-
DSP Fixed Maturity Plan Series 277 789 Days Direct Growth High Risk	-	0.0%	-	-
DSP Nifty Smallcap 250 Index Fund Direct Growth Very High Risk	0.6%	0.0%	₹17.58 Cr	-
DSP Nifty Midcap 150 Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹17.80 Cr	-
DSP Nifty500 Flexicap Quality 30 Index Fund Direct Growth Very High Risk	0.8%	0.0%	₹203.04 Cr	-7.3%
DSP Nifty IT Index Fund Direct Growth Very High Risk	0.5%	0.0%	₹112.17 Cr	-16.9%
DSP Nifty Healthcare Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹25.41 Cr	15.7%
DSP Silver ETF Fund of Fund Direct Growth Very High Risk	0.9%	0.0%	₹715.77 Cr	64.4%
DSP Nifty Private Bank Index Fund Direct Growth Very High Risk	0.6%	0.0%	₹110.35 Cr	0.4%
DSP BSE SENSEX Next 30 Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹26.06 Cr	6.9%
DSP Business Cycle Fund Direct Growth Very High Risk	1.3%	0.0%	₹1469.37 Cr	0.9%
DSP Nifty Top 10 Equal Weight Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹1139.69 Cr	-11.7%
DSP Nifty Bank Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹65.31 Cr	1.4%
DSP US Treasury Fund of Fund Direct Growth Very High Risk	0.2%	0.0%	₹68.65 Cr	5.5%
DSP Nifty Healthcare ETF Regular Growth Very High Risk	0.2%	-	₹14.94 Cr	11.4%
DSP Multicap Fund Direct Growth Low Risk	0.7%	1.0%	₹3024.92 Cr	0.7%
DSP Nifty Smallcap250 Quality 50 Index Fund Direct Growth Very High Risk	0.5%	0.0%	₹316.41 Cr	-5.1%
DSP Banking & Financial Services Fund Direct Growth Very High Risk	0.8%	0.0%	₹2183.66 Cr	8.9%
DSP Gold ETF Fund of Fund Direct Growth High Risk	1.0%	0.0%	₹556.84 Cr	31.8%
DSP Multi Asset Allocation Fund Direct Growth Very High Risk	0.6%	1.0%	₹10989.91 Cr	12.0%
DSP FMP - Series 264 - 60M - 17D Direct Growth Low Risk	-	0.0%	₹54.64 Cr	5.8%
DSP FMP Series 267 - 1246 Days Direct Growth Low Risk	-	0.0%	₹717.68 Cr	5.8%
DSP FMP Series 261 37 Month Direct Growth Moderate Risk	-	-	-	-
DSP Fixed Maturity Plan Series 270 1144 Days Direct Growth Low Risk	-	0.0%	₹180.35 Cr	5.8%
DSP FMP Series 268 - 1281 Days Direct Growth Low Risk	-	-	₹122.54 Cr	5.7%
DSP FMP Series 252 38 Month Direct Growth Moderate Risk	-	0.0%	-	-
DSP Banking & PSU Debt Fund Direct Growth Low Risk	0.3%	0.0%	₹3270.25 Cr	4.3%
DSP Dynamic Asset Allocation Fund Direct Growth Very High Risk	1.1%	1.0%	₹3821.11 Cr	3.4%
DSP Overnight Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹2853.61 Cr	5.3%
DSP Nifty 50 Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹1108.80 Cr	-6.1%
DSP Nifty Next 50 Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹1406.84 Cr	5.7%
DSP Healthcare Fund Direct Growth Very High Risk	0.7%	0.0%	₹3835.28 Cr	18.9%
DSP Global Allocation Fund Direct Growth Very High Risk	0.7%	0.0%	₹1593.30 Cr	5.1%
DSP Quant Fund Direct Growth Very High Risk	1.1%	0.0%	₹767.23 Cr	-2.9%
DSP Low Duration Fund Direct Growth Low to Moderate Risk	0.3%	0.0%	₹4750.25 Cr	6.0%
DSP Value Fund Direct Growth Very High Risk	1.7%	1.0%	₹2220.35 Cr	5.2%
DSP Nifty SDL Plus G-Sec Jun 2028 30:70 Index Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹1649.42 Cr	5.4%
DSP Bond Fund Direct Growth Moderately High risk	0.4%	0.0%	₹251.42 Cr	4.3%
DSP Flexi Cap Fund Direct Growth Very High Risk	0.8%	1.0%	₹12500.27 Cr	-1.1%
DSP Government Securities Direct Growth Moderate Risk	0.6%	0.0%	₹1213.03 Cr	3.7%
DSP Equity & Bond Fund Direct Growth High Risk	0.8%	1.0%	₹11758.92 Cr	-3.2%
DSP Focus Fund Direct Growth Very High Risk	1.1%	1.0%	₹2671.23 Cr	0.4%
DSP Credit Risk Fund Direct Growth Moderate Risk	0.4%	3.0%	₹309.74 Cr	11.0%
DSP India TIGER Fund Direct Growth Very High Risk	1.1%	1.0%	₹6467.31 Cr	14.2%
DSP Liquidity Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹27920.26 Cr	6.5%
DSP Regular Saving Fund Direct Growth Moderately High risk	0.6%	0.0%	₹178.35 Cr	3.5%
DSP Small Cap Fund Direct Growth Very High Risk	0.8%	1.0%	₹21658.64 Cr	18.7%
DSP Ultra Short Fund Direct Growth Moderate Risk	0.3%	0.0%	₹4599.23 Cr	6.7%

Risk Level

Your principal amount will be at Very High Risk

Take control of your wealth

Track and Analyse all your investments with Dezerv

Rated ★ 4.3+ on

Still got questions?
We're here to help.

What is the current NAV of DSP Healthcare Fund Regular Growth?

The NAV of DSP Healthcare Fund Regular Growth, as of 25-Sep-2026, is ₹45.74.

What are the returns of DSP Healthcare Fund Regular Growth?

The fund has generated 17.37% over the last 1 year and 21.34% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.

What is the portfolio composition of DSP Healthcare Fund Regular Growth?

The fund's allocation of assets is distributed as 97.13% in equities, 0.00% in bonds, and 2.87% in cash and cash equivalents.

Who manages the DSP Healthcare Fund Regular Growth?

The fund managers responsible for DSP Healthcare Fund Regular Growth are:-

Chirag Dagli

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme-related documents carefully. The NAVs of the schemes may go up or down depending upon the factors and forces affecting the securities market including the fluctuations in the interest rates. The past performance of the mutual funds is not necessarily indicative of the future performance of the schemes. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.

;

©2021-2026 Dezerv. All Rights Reserved

Dezerv Investments Pvt. Ltd. is a Portfolio Manager with SEBI Registration no. INP000007377, a member of BSE with SEBI Stock Broker Registration no. INZ000303136, and an Investment Manager to Category - I AIF-VCF-Angel Fund with SEBI Registration no. IN/AIF1/22-23/1066.

Mutual Fund distribution services are offered through Dezerv Distribution Services Pvt Limited, a wholly owned subsidiary with AMFI Registration No.: ARN -248439. **Mutual fund investments are subject to market risks, read all scheme related documents carefully.** Terms and conditions of the website are applicable. Privacy policy of the website is applicable.

DSP Healthcare Fund Regular Growth

Fund Overview